Contract

Infant and Paediatric SARS-CoV-2 Vaccine Supply (2025)

  • Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

F03: Contract award notice

Notice identifier: 2025/S 000-039968

Procurement identifier (OCID): ocds-h6vhtk-048b76 (view related notices)

Published 15 July 2025, 1:44pm



Section one: Contracting authority

one.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

10 South Colonnade

London

E14 4PU

Email

vmc.vaccines@ukhsa.gov.uk

Country

United Kingdom

Region code

UKI42 - Tower Hamlets

Internet address(es)

Main address

https://www.gov.uk/government/organisations/uk-health-security-agency

Buyer's address

https://www.gov.uk/government/organisations/uk-health-security-agency

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Infant and Paediatric SARS-CoV-2 Vaccine Supply (2025)

Reference number

CM/PHV/25/C334432

two.1.2) Main CPV code

  • 33651600 - Vaccines

two.1.3) Type of contract

Supplies

two.1.4) Short description

Contract for the supply of immunisation products indicated for the prevention of, or protection against, SARS-CoV-2 in infant and paediatric groups (2025).

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £1

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKJ44 - East Kent
Main site or place of performance

Sandwich, Kent

two.2.4) Description of the procurement

The contract was awarded for Lot 1, Infant and Paediatrics SARS-CoV-2 vaccine, via a further competition conducted under the SARS-CoV-2 vaccine DPS (FTS ref: 2024/S 000-026083).

two.2.5) Award criteria

Quality criterion - Name: Ability to update the vaccine / Weighting: NA

Quality criterion - Name: Programme Risk / Weighting: NA

Quality criterion - Name: Programme responsiveness / Weighting: NA

Quality criterion - Name: Reducing waste / Weighting: NA

Quality criterion - Name: Social Value / Weighting: NA

Cost criterion - Name: Cost effectiveness of deployed cost per dose / Weighting: NA

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Restricted procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.1) Previous publication concerning this procedure

Notice number: 2024/S 000-026083


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

17 June 2025

five.2.2) Information about tenders

Number of tenders received: 1

Number of tenders received from SMEs: 0

Number of tenders received by electronic means: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

PFIZER LIMITED

Walton Oaks, Dorking Road

Kent

KT20 7NS

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

00526209

Internet address

http://www.pfizer.co.uk

The contractor is an SME

No

five.2.4) Information on value of contract/lot (excluding VAT)

Initial estimated total value of the contract/lot: £1

Total value of the contract/lot: £1


Section six. Complementary information

six.3) Additional information

The contracts are for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories to undertake their respective immunisation programmes.

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom